Psilocybin for Depression
Journal watch November 6, 2020 DOI: 10.1056/nejm-jw.na52780 via OpenAlex
Summary
AI-generated from the abstractPsilocybin, a hallucinogenic compound, shows potential usefulness for depressed cancer patients and those with treatment-resistant depression, based on exploratory studies. The text notes that these investigations are preliminary and do not provide definitive conclusions.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Intervention | Psilocybin |
| Key finding | Exploratory studies suggest psilocybin may be useful for depressed cancer patients and patients with treatment-resistant depression. |
Abstract
Exploratory studies have examined the usefulness of the hallucinogen psilocybin for depressed cancer patients and patients with treatment-resistant